Company Overview of Adlyfe Inc.
Adlyfe Inc., an early stage biotechnology company, develops solutions for the early detection of protein misfolding diseases. The company focuses on creating in vitro diagnostic and imaging tests for Alzheimer’s disease and other neurodegenerative diseases. It offers Pronucleon, a platform technology that uses custom-synthesized peptides that allows signal amplification to map the surface of rare proteins. Adlyfe Inc. was founded in 2003 and is based in Rockville, Maryland.
9430 Key West Avenue
Rockville, MD 20850
Founded in 2003
Key Executives for Adlyfe Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Adlyfe Inc., please visit www.adlyfe.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.